Autoimmune Disease Specialist in Shanghai: The Short Answer

Consulting an autoimmune disease specialist in Shanghai at Renji Hospital costs between $150 and $800 USD depending on whether you use the standard public outpatient clinic or the hospital’s international VIP department. The standard rheumatology consultation fee is roughly $15–50, while the international department charges $150–300 for the same specialist’s time. But the real costs—and the real barriers—go far beyond the consultation fee itself.

Renji Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, consistently ranks among China’s top rheumatology and immunology centers. Its Department of Rheumatology and Immunology handles over 300,000 outpatient visits annually. For a foreign patient, that volume is both a strength and a challenge. The clinical expertise is deep. The navigation is not simple.

While a patient in the United States might wait 4–6 weeks for a rheumatology appointment and pay $350–600 for a specialist consultation without insurance, Shanghai offers a different trade-off: lower prices, faster access through the right channels, and a hospital system that treats autoimmune disease at a scale most Western institutions never see. But you need to understand how the system actually works before booking a flight.

Who This Is Right For — and Who It Isn’t

Traveling to Shanghai for autoimmune disease care makes sense for a specific profile of patient. It is not a universal solution, and we say that plainly because the wrong decision costs more than money.

You are typically a good candidate if:

• You have a confirmed or suspected autoimmune condition—lupus, rheumatoid arthritis, Sjögren’s syndrome, ankylosing spondylitis, vasculitis, or myositis—and want a second opinion from a high-volume rheumatology center.
• You already have medical records, lab results, and imaging that can be reviewed remotely before you travel.
• You are comfortable with a staged approach: written second opinion first, video consultation second, in-person visit only if needed.
• Your condition is stable enough that you do not need emergency intervention during travel.
• You are seeking treatment costs that are 50–80% lower than comparable care in the United States, even after travel expenses.

You should not pursue this if:

• You are in an active flare requiring hospitalization within days. Travel during a severe flare is dangerous and unnecessary.
• You cannot provide translated medical records. Chinese specialists will not give meaningful opinions without documentation.
• You expect Western-style scheduling where you book a specific doctor online and show up. The Chinese public hospital system does not work that way for regular outpatient clinics.
• You are on a medication regimen that cannot be interrupted or adjusted during travel.
• You need a solid-organ transplant evaluation. That is outside the scope of rheumatology care and involves entirely different pathways.

Being honest about who should not travel is how we protect patients from bad decisions. If you fall into the second list, a remote consultation may still be valuable—but do not board a plane expecting a different reality than the one described here.

The Options, Compared

Autoimmune disease care in Shanghai is not a single pathway. There are three distinct access routes, and they differ dramatically in price, speed, and experience.

The standard outpatient route is dramatically cheaper but functionally inaccessible to most foreigners without Chinese language ability. The international department is the realistic path for patients traveling from abroad. And the remote options—written second opinion or video consultation—let you test the waters before spending thousands on flights and accommodation.

Which column fits you? If you are already in Shanghai or speak Mandarin, the public clinic is viable. If you are planning travel from overseas, start with a remote consultation. It costs less than a round-trip flight and tells you whether Renji is actually the right hospital for your specific condition.

Renji Hospital’s Rheumatology Department: What Makes It Different

Renji Hospital’s Department of Rheumatology and Immunology is not just a large department—it is a national reference center. Founded in 1979, it was one of the first dedicated rheumatology units in China. Today it operates over 100 inpatient beds and manages some of the most complex autoimmune cases in the country.

The department’s clinical volume is staggering by Western standards. More than 300,000 outpatient visits per year means the specialists see rare presentations regularly that a typical Western rheumatologist might encounter once or twice in a career. For lupus patients, this matters. Systemic lupus erythematosus affects approximately 1 in 1,000 people in Western populations but is more prevalent in Asian populations. Renji’s clinicians manage thousands of lupus cases annually.

Research output backs up the clinical reputation. Renji’s rheumatology team has published extensively in journals including Arthritis & Rheumatology and Annals of the Rheumatic Diseases. The department runs multiple clinical trials for biologic therapies targeting rheumatoid arthritis, lupus nephritis, and spondyloarthritis. For a patient with refractory disease, access to these trials can be a deciding factor.

But volume and research credentials do not automatically translate to a smooth experience for a foreign patient. The public wards are crowded. The pace is fast. Consultations are brief by Western standards—often 10–15 minutes. You need a strategy for getting the most out of that time, and you need someone who can translate both language and medical culture.

For a broader view of how Renji compares to other top institutions, see our rankings of China’s leading hospitals and the specialty-specific department rankings we maintain for international patients.

What Autoimmune Disease Treatment Costs at Renji Hospital

Let’s get specific about numbers, because vague answers do not help anyone plan a medical trip. These figures reflect 2025 price levels for international patients using the VIP or international department channels. All prices vary by hospital and case complexity.

A new patient consultation with a senior rheumatologist in Renji’s international department runs $150–300. Follow-up visits cost $100–200. Comprehensive lab panels for autoimmune markers—ANA, anti-dsDNA, complement levels, inflammatory markers, organ function tests—typically run $200–500 depending on how many markers are ordered.

Imaging adds to the total. A joint ultrasound costs $80–150. An MRI of affected joints or organs runs $300–600. If a biopsy is needed—kidney biopsy for lupus nephritis, for example—the procedure costs $800–1,500 including pathology analysis.

Medication costs depend entirely on what is prescribed. Conventional disease-modifying drugs like methotrexate or hydroxychloroquine cost $20–80 per month. Biologics are the expensive category. A monthly dose of a TNF inhibitor or IL-6 inhibitor costs $800–2,500 in China, which is still 40–60% less than the same drug in the United States. Some newer biologics approved in China are not yet available in Western markets at all.

A typical international patient coming for initial evaluation and treatment planning should budget $2,000–5,000 for the first trip, excluding flights and accommodation. That covers consultation, comprehensive testing, imaging, and initial medication. The same workup in the US would cost $8,000–15,000 without insurance.

Practical Considerations: Records, Visas, and Follow-Up

The logistics of seeing an autoimmune disease specialist in Shanghai are manageable if you prepare correctly. The most common failure point is documentation.

Bring every relevant medical record you have. That means lab results, imaging reports and actual images, biopsy reports, medication history, and a summary letter from your current rheumatologist. If records are not in English or Chinese, they need professional translation. Chinese specialists are meticulous about reviewing documentation, and they will not make treatment decisions based on incomplete information.

For the visa, foreign nationals traveling to China for medical treatment apply for an S2 visa with documentation from the treating hospital. The hospital’s international department issues an invitation letter and treatment confirmation that supports the visa application. Family members accompanying the patient apply for S2 visas as well. Processing typically takes 1–3 weeks depending on your home country’s Chinese embassy or consulate. Requirements change, so verify current rules with the embassy before applying.

Payment is straightforward but different from Western norms. Public hospitals in China, including Renji’s international department, require pre-payment. You deposit funds at registration and charges are deducted as services are rendered. International credit cards are accepted at the international department but not always at the standard outpatient pharmacy. Bring a card that works in China or arrange funds transfer in advance.

Insurance is the other piece. Renji’s international department provides itemized receipts and medical reports suitable for insurance claims, but you pay first and seek reimbursement after. Direct billing is rare in Chinese public hospitals, even in international departments. If you have a policy that covers overseas treatment, confirm the claims process before you travel.

Follow-up after returning home is where many patients stumble. Your Chinese specialist will give you a treatment plan, but you need a home rheumatologist willing to continue that plan. Not all Western doctors are comfortable following a treatment regimen from another country. Discuss this with your home physician before you decide to travel. A video consultation with your Renji specialist can bridge the gap if questions arise later.

How to Book an Appointment with an Autoimmune Specialist in Shanghai

Frequently Asked Questions